COVID-19: Vaccines
Über den Vortrag
Der Vortrag „COVID-19: Vaccines“ von Sean Elliott, MD ist Bestandteil des Kurses „Year 4 – Selective Sub-Internship“.
Quiz zum Vortrag
What is the minimum level of efficacy required for FDA approval of a vaccine in the US?
- 50%
- 35%
- 65%
- 80%
- 95%
What is the level of efficacy of the Pfizer BioNTech (an mRNA vaccine) in individuals ages 5 to 11?
- 91%
- 50%
- 65%
- 80%
- 90%
How does an mRNA vaccine work to produce immunity?
- A nanoparticle-encapsulated lipid that includes mRNA specifically for the SARS-CoV-2 spike protein gene is injected into the host to produce an immune response.
- Inactive viral mRNA triggers an immune response so that T and B cells are already activated in case of exposure to a new virus.
- The mRNA of a non-replicating adenovirus is injected into the vaccine recipient.
- Viral mRNA from the SARS-CoV-2 virus is injected, causing an immune memory response to recognize and fight off future infection.
- A synthetic nanoparticle already coated with the spike protein is injected into the host to produce an immune response to future SARS-CoV-2 mRNA, if exposed.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages COVID-19: Vaccines
Sean Elliott, MD
Dr. Sean Elliott is the Professor of Clinical Pediatrics and the Associate Chair for the Department of Pediatrics at The University of Arizona, USA.
He obtained his MD from Columbia University College of Physicians and Surgeons in 1993. Currently, he is Pediatric Infectious Disease Specialist at the University of Arizona Medical Center.
He devotes time to Quality Improvement, graduate medical education efficacy and his scholarship with the Tucson Hospitals Medical Education Program (THMEP).
Within Lecturio, Dr. Elliott teaches courses on Microbiology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
